{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T06:37:06Z","timestamp":1790318226404,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T00:00:00Z","timestamp":1729728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T00:00:00Z","timestamp":1729728000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Key Research and Development Program of Nanning","award":["20233069"],"award-info":[{"award-number":["20233069"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biotechnol"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s12033-024-01299-z","type":"journal-article","created":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T03:03:19Z","timestamp":1729738999000},"page":"3946-3959","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Molecular Indicator for Distinguishing Multi-drug-Resistant Tuberculosis from Drug Sensitivity Tuberculosis and Potential Medications for Treatment"],"prefix":"10.1007","volume":"67","author":[{"given":"Shulin","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donghui","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiqian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yibo","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1183-6228","authenticated-orcid":false,"given":"Guanqiao","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,24]]},"reference":[{"key":"1299_CR1","unstructured":"Global tuberculosis report 2023. Geneva: World Health Organization; 2023. Licence: CC BY-NC-SA 3.0 IGO. 2023. p. https:\/\/www.who.int\/publications\/i\/item\/9789240061729."},{"issue":"5","key":"1299_CR2","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/nrd4001","volume":"12","author":"A Zumla","year":"2013","unstructured":"Zumla, A., Nahid, P., & Cole, S. T. (2013). Advances in the development of new tuberculosis drugs and treatment regimens. Nature Reviews Drug Discovery, 12(5), 388\u2013404.","journal-title":"Nature Reviews Drug Discovery"},{"issue":"3","key":"1299_CR3","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1111\/j.1440-1843.2010.01738.x","volume":"15","author":"CY Chiang","year":"2010","unstructured":"Chiang, C. Y., Centis, R., & Migliori, G. B. (2010). Drug-resistant tuberculosis: Past, present, future. Respirology, 15(3), 413\u2013432.","journal-title":"Respirology"},{"issue":"6","key":"1299_CR4","doi-asserted-by":"publisher","first-page":"5202","DOI":"10.3390\/ijms24065202","volume":"24","author":"SSR Alsayed","year":"2023","unstructured":"Alsayed, S. S. R., & Gunosewoyo, H. (2023). Tuberculosis: Pathogenesis, current treatment regimens and new drug targets. International Journal of Molecular Sciences, 24(6), 5202.","journal-title":"International Journal of Molecular Sciences"},{"key":"1299_CR5","unstructured":"WHO.Consolidated Guidelines on drug-resistant tuberculosis treatment. World Health Organization, 2019; Licence: CC BY-NC-SA 30 IGO. 2019."},{"issue":"10362","key":"1299_CR6","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1016\/S0140-6736(22)01883-9","volume":"400","author":"J Mok","year":"2022","unstructured":"Mok, J., Lee, M., Kim, D. K., Kim, J. S., Jhun, B. W., Jo, K. W., Jeon, D., Lee, T., Lee, J. Y., Park, J. S., & Lee, S. H. (2022). 9 Months of delamanid, linezolid, levofloxacin, and pyrazinamide versus conventional therapy for treatment of fluoroquinolone-sensitive multidrug-resistant tuberculosis (MDR-END): A multicentre, randomised, open-label phase 2\/3 non-inferiority trial in South Korea. Lancet, 400(10362), 1522\u201330.","journal-title":"Lancet"},{"issue":"5","key":"1299_CR7","doi-asserted-by":"publisher","first-page":"850","DOI":"10.4184\/asj.2016.10.5.850","volume":"10","author":"A Sharma","year":"2016","unstructured":"Sharma, A., Chhabra, H. S., Mahajan, R., Chabra, T., & Batra, S. (2016). Magnetic resonance imaging and GeneXpert: A rapid and accurate diagnostic tool for the management of tuberculosis of the spine. Asian Spine Journal, 10(5), 850\u2013856.","journal-title":"Asian Spine Journal"},{"issue":"9","key":"1299_CR8","doi-asserted-by":"publisher","first-page":"e672","DOI":"10.1016\/S2666-5247(22)00116-1","volume":"3","author":"I Finci","year":"2022","unstructured":"Finci, I., Albertini, A., Merker, M., Andres, S., Bablishvili, N., Barilar, I., C\u00e1ceres, T., Crudu, V., Gotuzzo, E., Hapeela, N., & Hoffmann, H. (2022). Investigating resistance in clinical Mycobacterium tuberculosis complex isolates with genomic and phenotypic antimicrobial susceptibility testing: A multicentre observational study. Lancet Microbe, 3(9), e672\u2013e82.","journal-title":"Lancet Microbe"},{"key":"1299_CR9","unstructured":"WHO. 2023. Use of targeted next-generation sequencing to detect drug-resistant tuberculosis. Rapid communication, (7)."},{"issue":"9","key":"1299_CR10","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/s41579-019-0214-5","volume":"17","author":"CJ Meehan","year":"2019","unstructured":"Meehan, C. J., Goig, G. A., Kohl, T. A., Verboven, L., Dippenaar, A., Ezewudo, M., Farhat, M. R., Guthrie, J. L., Laukens, K., Miotto, P., & Ofori-Anyinam, B. (2019). Whole genome sequencing of Mycobacterium tuberculosis: Current standards and open issues. Nature Reviews Microbiology, 17(9), 533\u201345.","journal-title":"Nature Reviews Microbiology"},{"key":"1299_CR11","unstructured":"WHO. High-priority target product profiles for new tuberculosis diagnostics: Report of a consensus meeting 2014. 2014."},{"issue":"2","key":"1299_CR12","doi-asserted-by":"publisher","first-page":"2261561","DOI":"10.1080\/22221751.2023.2261561","volume":"12","author":"W Xiaocui","year":"2023","unstructured":"Xiaocui, W., Tan, G., Ma, J., Yang, J., Guo, Y., Haiwen, L., Ke, H., Li, M., Tang, Y.-W., Sha, W., & Fangyou, Y. (2023). Assessment of the Cepheid 3-gene host response fingerstick blood test (MTB-HR) on rapid diagnosis of tuberculosis. Emerging Microbes & Infections, 12(2), 2261561.","journal-title":"Emerging Microbes & Infections"},{"issue":"2","key":"1299_CR13","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1159\/000528274","volume":"102","author":"JM Aguilar","year":"2023","unstructured":"Aguilar, J. M., Diaz, A. A., Abulfathi, L. H. M., te Brake, J., van Ingen, S., Kuipers, C.M.-E., Raaijmakers, J., Svensson, E. M., & Boeree, M. J. (2023). New and repurposed drugs for the treatment of active tuberculosis: An update for clinicians. Respiration, 102(2), 83\u2013100.","journal-title":"Respiration"},{"issue":"5","key":"1299_CR14","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/s41573-024-00897-5","volume":"23","author":"V Dartois","year":"2024","unstructured":"Dartois, V., & Dick, T. (2024). Therapeutic developments for tuberculosis and nontuberculous mycobacterial lung disease. Nature Reviews. Drug Discovery, 23(5), 381\u2013403.","journal-title":"Nature Reviews. Drug Discovery"},{"issue":"1","key":"1299_CR15","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/nrc2044","volume":"7","author":"J Lamb","year":"2007","unstructured":"Lamb, J. (2007). The connectivity map: A new tool for biomedical research. Nature Reviews Cancer, 7(1), 54\u201360.","journal-title":"Nature Reviews Cancer"},{"issue":"13","key":"1299_CR16","doi-asserted-by":"publisher","first-page":"3284","DOI":"10.3390\/cancers14133284","volume":"14","author":"Y Xiao","year":"2022","unstructured":"Xiao, Y., Zhang, B., Cloyd, J. M., Alaimo, L., Gang, X., Shunda, D., Mao, Y., & Pawlik, T. M. (2022). Novel drug candidate prediction for intrahepatic cholangiocarcinoma via hub gene network analysis and connectivity mapping. Cancers (Basel), 14(13), 3284.","journal-title":"Cancers (Basel)"},{"key":"1299_CR17","doi-asserted-by":"publisher","first-page":"850217","DOI":"10.3389\/fnagi.2022.850217","volume":"14","author":"J Zhou","year":"2022","unstructured":"Zhou, J., Li, Q., Wu, W., Zhang, X., Zuo, Z., Lu, Y., Zhao, H., & Wang, Z. (2022). Discovery of novel drug candidates for alzheimer\u2019s disease by molecular network modeling. Frontiers in Aging Neuroscience, 14, 850217.","journal-title":"Frontiers in Aging Neuroscience"},{"key":"1299_CR18","doi-asserted-by":"publisher","first-page":"1099654","DOI":"10.3389\/fmolb.2023.1099654","volume":"10","author":"Y Yu","year":"2023","unstructured":"Yu, Y., Jiang, X. X., & Li, J. C. (2023). Biomarker discovery for tuberculosis using metabolomics. Frontiers in Molecular Biosciences, 10, 1099654.","journal-title":"Frontiers in Molecular Biosciences"},{"issue":"4","key":"1299_CR19","doi-asserted-by":"publisher","first-page":"3935","DOI":"10.1007\/s11033-023-08307-6","volume":"50","author":"P Madamarandawala","year":"2023","unstructured":"Madamarandawala, P., Rajapakse, S., Gunasena, B., Madegedara, D., & Magana-Arachchi, D. (2023). A host blood transcriptional signature differentiates multi-drug\/rifampin-resistant tuberculosis (MDR\/RR-TB) from drug susceptible tuberculosis: A pilot study. Molecular Biology Reports, 50(4), 3935\u20133943.","journal-title":"Molecular Biology Reports"},{"key":"1299_CR20","first-page":"7486425","volume":"2016","author":"Z Liu","year":"2016","unstructured":"Liu, Z., Qie, S., Li, L., Xiu, B., Yang, X., Dai, Z., Zhang, X., Duan, C., Que, H., Zhao, P., & Johnson, H. (2016). Identification of novel RD1 antigens and their combinations for diagnosis of sputum smear-\/culture+ TB patients. BioMed Research International, 2016, 7486425.","journal-title":"BioMed Research International"},{"key":"1299_CR21","doi-asserted-by":"publisher","first-page":"102140","DOI":"10.1016\/j.tube.2021.102140","volume":"132","author":"T Liang","year":"2022","unstructured":"Liang, T., Chen, J., Xu, G., Zhang, Z., Xue, J., Zeng, H., Jiang, J., Chen, T., Qin, Z., Li, H., & Ye, Z. (2022). Ferroptosis-related gene SOCS1, a marker for tuberculosis diagnosis and treatment, involves in macrophage polarization and facilitates bone destruction in tuberculosis. Tuberculosis, 132, 102140.","journal-title":"Tuberculosis"},{"issue":"3","key":"1299_CR22","doi-asserted-by":"publisher","first-page":"2003492","DOI":"10.1183\/13993003.03492-2020","volume":"58","author":"J Heyckendorf","year":"2021","unstructured":"Heyckendorf, J., Marwitz, S., Reimann, M., Avsar, K., DiNardo, A. R., G\u00fcnther, G., Hoelscher, M., Ibraim, E., Kalsdorf, B., Kaufmann, S. H. E. ., Kontsevaya, I., van Leth, F., Mandalakas, A. M., Maurer, F. P., M\u00fcller, M., Nitschkowski, D., Olaru, I. D., Popa, C., Rachow, A., \u2026 Lange, C. (2021). Prediction of anti-tuberculosis treatment duration based on a 22-gene transcriptomic model. European Respiratory Journal., 58(3), 2003492.","journal-title":"European Respiratory Journal."},{"issue":"3","key":"1299_CR23","doi-asserted-by":"publisher","first-page":"649","DOI":"10.55730\/1300-0144.5357","volume":"52","author":"C \u00c7avu\u015fo\u011flu","year":"2022","unstructured":"\u00c7avu\u015fo\u011flu, C., \u00c7o\u011fulu, \u00d6., Durmaz, A., Cengisiz, Z., Y\u0131lmaz, F. F., Ta\u015fbakan, M. S., Ta\u015fbakan, M., G\u00fcnd\u00fcz, C., Bi\u00e7men, C., Karaman, O., Ta\u015flidere, H., Akin, H., Akarca, T., & Dereli, M. S. (2022). Investigation of miRNA and cytokine expressions in latent tuberculosis infection and active tuberculosis. Turkish Journal of Medical Sciences, 52(3), 649\u2013657.","journal-title":"Turkish Journal of Medical Sciences"},{"key":"1299_CR24","doi-asserted-by":"publisher","first-page":"109588","DOI":"10.1016\/j.intimp.2022.109588","volume":"116","author":"C Zhou","year":"2023","unstructured":"Zhou, C., Liang, T., Jiang, J., Chen, J., Chen, T., Huang, S., Chen, L., Sun, X., Chen, W., Zhu, J., & Wu, S. (2023). MMP9 and STAT1 are biomarkers of the change in immune infiltration after anti-tuberculosis therapy, and the immune status can identify patients with spinal tuberculosis. International Immunopharmacology, 116, 109588.","journal-title":"International Immunopharmacology"},{"key":"1299_CR25","doi-asserted-by":"publisher","first-page":"D447","DOI":"10.1093\/nar\/gku1003","volume":"43","author":"D Szklarczyk","year":"2015","unstructured":"Szklarczyk, D., Franceschini, A., Wyder, S., Forslund, K., Heller, D., Huerta-Cepas, J., Simonovic, M., Roth, A., Santos, A., Tsafou, K. P., & Kuhn, M. (2015). STRING v10: Protein-protein interaction networks, integrated over the tree of life. Nucleic acids research, 43, D447-52.","journal-title":"Nucleic acids research"},{"key":"1299_CR26","doi-asserted-by":"publisher","first-page":"101704","DOI":"10.1016\/j.artmed.2019.101704","volume":"99","author":"AM Tai","year":"2019","unstructured":"Tai, A. M., Albuquerque, A., Carmona, N. E., Subramanieapillai, M., Cha, D. S., Sheko, M., Lee, Y., Mansur, R., & McIntyre, R. S. (2019). Machine learning and big data: Implications for disease modeling and therapeutic discovery in psychiatry. Artificial Intelligence in Medicine, 99, 101704.","journal-title":"Artificial Intelligence in Medicine"},{"issue":"12","key":"1299_CR27","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1038\/nbt1206-1565","volume":"24","author":"WS Noble","year":"2006","unstructured":"Noble, W. S. (2006). What is a support vector machine? Nature Biotechnology, 24(12), 1565\u20131567.","journal-title":"Nature Biotechnology"},{"issue":"11","key":"1299_CR28","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1111\/1753-0407.13444","volume":"15","author":"Y Ling","year":"2023","unstructured":"Ling, Y., Chen, X., Zhou, M., Zhang, M., Luo, D., Wang, W., Chen, B., & Jiang, J. (2023). The effect of diabetes mellitus on tuberculosis in eastern China: A decision-tree analysis based on a real-world study. Journal of Diabetes, 15(11), 920\u2013930.","journal-title":"Journal of Diabetes"},{"key":"1299_CR29","doi-asserted-by":"publisher","first-page":"1159713","DOI":"10.3389\/fimmu.2023.1159713","volume":"14","author":"J Shen","year":"2023","unstructured":"Shen, J., Zhao, C., Zhang, H., Zhou, P., & Li, Z. (2023). Classification of tuberculosis-related programmed cell death-related patient subgroups and associated immune cell profiling. Frontiers in Immunology, 14, 1159713.","journal-title":"Frontiers in Immunology"},{"issue":"13","key":"1299_CR30","doi-asserted-by":"publisher","first-page":"i555","DOI":"10.1093\/bioinformatics\/bty271","volume":"34","author":"RK Powers","year":"2018","unstructured":"Powers, R. K., Goodspeed, A., Pielke-Lombardo, H., Tan, A. C., & Costello, J. C. (2018). GSEA-InContext: Identifying novel and common patterns in expression experiments. Bioinformatics, 34(13), i555\u2013i564.","journal-title":"Bioinformatics"},{"key":"1299_CR31","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s13756-019-0516-4","volume":"8","author":"H Ghajavand","year":"2019","unstructured":"Ghajavand, H., Kargarpour Kamakoli, M., Khanipour, S., Pourazar Dizaji, S., Masoumi, M., Rahimi Jamnani, F., Fateh, A., Yaseri, M., Siadat, S. D., & Vaziri, F. (2019). Scrutinizing the drug resistance mechanism of multi- and extensively drug resistant Mycobacterium tuberculosis: Mutations versus efflux pumps. Antimicrobial Resistance & Infection Control, 8, 70.","journal-title":"Antimicrobial Resistance & Infection Control"},{"issue":"5","key":"1299_CR32","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1159\/000226425","volume":"55","author":"AA Velayati","year":"2009","unstructured":"Velayati, A. A., Farnia, P., Ibrahim, T. A., Haroun, R. Z., Kuan, H. O., Ghanavi, J., Farnia, P., Kabarei, A. N., Tabarsi, P., Omar, A. R., & Varahram, M. (2009). Differences in cell wall thickness between resistant and nonresistant strains of Mycobacterium tuberculosis: Using transmission electron microscopy. Chemotherapy, 55(5), 303\u20137.","journal-title":"Chemotherapy"},{"issue":"1","key":"1299_CR33","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1128\/AAC.01972-12","volume":"57","author":"L Gannoun-Zaki","year":"2013","unstructured":"Gannoun-Zaki, L., Alibaud, L., & Kremer, L. (2013). Point mutations within the fatty acid synthase type II dehydratase components HadA or HadC contribute to isoxyl resistance in Mycobacterium tuberculosis. Antimicrobial Agents and Chemotherapy, 57(1), 629\u2013632.","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"1299_CR34","doi-asserted-by":"publisher","first-page":"e81177","DOI":"10.7554\/eLife.81177","volume":"22","author":"AI Wong","year":"2023","unstructured":"Wong, A. I., Beites, T., Planck, K. A., Fieweger, R. A., Eckartt, K. A., Li, S., Poulton, N. C., VanderVen, B. C., Rhee, K. Y., Schnappinger, D., & Ehrt, S. (2023). Cyclic AMP is a critical mediator of intrinsic drug resistance and fatty acid metabolism in M. tuberculosis. Elife, 22, e81177.","journal-title":"Elife"},{"issue":"12","key":"1299_CR35","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.5588\/ijtld.15.0325","volume":"19","author":"W Chung","year":"2015","unstructured":"Chung, W., Lee, K., Jung, Y., Kim, Y., Park, J., Sheen, S., Lee, J., Kang, D., & Park, K. (2015). Serum CXCR3 ligands as biomarkers for the diagnosis and treatment monitoring of tuberculosis. The International Journal of Tuberculosis and Lung Disease, 19(12), 1476\u201384.","journal-title":"The International Journal of Tuberculosis and Lung Disease"},{"issue":"9","key":"1299_CR36","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1164\/rccm.201304-0803OC","volume":"188","author":"R Gopal","year":"2013","unstructured":"Gopal, R., Monin, L., Torres, D., Slight, S., Mehra, S., McKenna, K. C., Fallert Junecko, B. A., Reinhart, T. A., Kolls, J., B\u00e1ez-Salda\u00f1a, R., & Cruz-Lagunas, A. (2013). S100A8\/A9 proteins mediate neutrophilic inflammation and lung pathology during tuberculosis. American Journal of Respiratory and Critical Care Medicine, 188(9), 1137\u201346.","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"1299_CR37","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbab071","author":"N Zhang","year":"2021","unstructured":"Zhang, N., Luo, X., Huang, J., Song, H., Zhang, X., Huang, H., Zhao, S., & Wang, G. (2021). The landscape of different molecular modules in an immune microenvironment during tuberculosis infection. Briefings in Bioinformatics. https:\/\/doi.org\/10.1093\/bib\/bbab071","journal-title":"Briefings in Bioinformatics"},{"key":"1299_CR38","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.jinf.2023.03.020","volume":"86","author":"Y Wang","year":"2023","unstructured":"Wang, Y., Sun, Q., Zhang, Y., Li, X., Liang, Q., Guo, R., Zhang, L., Han, X., Wang, J., Shao, L., & Xue, Y. (2023). Systemic immune dysregulation in severe tuberculosis patients revealed by a single-cell transcriptome atlas. Journal of Infection, 86, 421\u2013438.","journal-title":"Journal of Infection"},{"issue":"15","key":"1299_CR39","doi-asserted-by":"publisher","first-page":"7270","DOI":"10.1111\/jcmm.16756","volume":"25","author":"L Wu","year":"2021","unstructured":"Wu, L., Cheng, Q., Wen, Z., Song, Y., Zhu, Y., & Wang, L. (2021). IRF1 as a potential biomarker in Mycobacterium tuberculosis infection. Journal of Cellular and Molecular Medicine, 25(15), 7270\u20137279.","journal-title":"Journal of Cellular and Molecular Medicine"},{"issue":"11","key":"1299_CR40","doi-asserted-by":"publisher","first-page":"2516","DOI":"10.1158\/1535-7163.MCT-17-0379","volume":"16","author":"V Lifshitz","year":"2017","unstructured":"Lifshitz, V., Priceman, S. J., Li, W., Cherryholmes, G., Lee, H., Makovski-Silverstein, A., Borriello, L., DeClerck, Y. A., & Yu, H. (2017). Sphingosine-1-phosphate receptor-1 promotes environment-mediated and acquired chemoresistance. Molecular cancer therapeutics., 16(11), 2516\u201327.","journal-title":"Molecular cancer therapeutics."},{"key":"1299_CR41","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23031112","author":"M Druszczy\u0144ska","year":"2022","unstructured":"Druszczy\u0144ska, M., Godkowicz, M., Kulesza, J., Wawrocki, S., & Fol, M. (2022). Cytokine receptors-regulators of antimycobacterial immune response. International Journal of Molecular Sciences. https:\/\/doi.org\/10.3390\/ijms23031112","journal-title":"International Journal of Molecular Sciences"},{"key":"1299_CR42","doi-asserted-by":"publisher","first-page":"6654220","DOI":"10.1155\/2021\/6654220","volume":"2021","author":"R Oca\u00f1a-Guzm\u00e1n","year":"2021","unstructured":"Oca\u00f1a-Guzm\u00e1n, R., T\u00e9llez-Navarrete, N. A., Ram\u00f3n-Luing, L. A., Herrera, I., De Ita, M., Carrillo-Alduenda, J. L., Chore\u00f1o-Parra, J. A., Medina-Quero, K., Z\u00fa\u00f1iga, J., & Ch\u00e1vez-Gal\u00e1n, L. (2021). Leukocytes from patients with drug-sensitive and multidrug-resistant tuberculosis exhibit distinctive profiles of chemokine receptor expression and migration capacity. Journal of Immunology Research, 2021, 6654220.","journal-title":"Journal of Immunology Research"},{"issue":"25","key":"1299_CR43","doi-asserted-by":"publisher","first-page":"4682","DOI":"10.1016\/j.cell.2022.10.025","volume":"185","author":"JL Flynn","year":"2022","unstructured":"Flynn, J. L., & Chan, J. (2022). Immune cell interactions in tuberculosis. Cell, 185(25), 4682\u20134702.","journal-title":"Cell"},{"issue":"5","key":"1299_CR44","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1084\/jem.20151248","volume":"213","author":"Y Liu","year":"2016","unstructured":"Liu, Y., Tan, S., Huang, L., Abramovitch, R. B., Rohde, K. H., Zimmerman, M. D., Chen, C., Dartois, V., VanderVen, B. C., & Russell, D. G. (2016). Immune activation of the host cell induces drug tolerance in Mycobacterium tuberculosis both in vitro and in vivo. Journal of Experimental Medicine, 213(5), 809\u201325.","journal-title":"Journal of Experimental Medicine"},{"issue":"5","key":"1299_CR45","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/s41419-018-0426-z","volume":"9","author":"L Ladislau","year":"2018","unstructured":"Ladislau, L., Portilho, D. M., Courau, T., Solares-P\u00e9rez, A., Negroni, E., Lain\u00e9, J., Klatzmann, D., Bonomo, A., Allenbach, Y., Benveniste, O., & Riederer, I. (2018). Activated dendritic cells modulate proliferation and differentiation of human myoblasts. Cell Death & Disease, 9(5), 551.","journal-title":"Cell Death & Disease"},{"issue":"9","key":"1299_CR46","first-page":"4478","volume":"13","author":"M Zhang","year":"2023","unstructured":"Zhang, M., Hei, R., Zhou, Z., Xiao, W., Liu, X., & Chen, Y. (2023). Macrophage polarization involved the inflammation of chronic obstructive pulmonary disease by S1P\/HDAC1 signaling. American Journal of Cancer Research, 13(9), 4478\u20134489.","journal-title":"American Journal of Cancer Research"},{"issue":"7","key":"1299_CR47","doi-asserted-by":"publisher","first-page":"e2215512120","DOI":"10.1073\/pnas.2215512120","volume":"120","author":"MA Lake","year":"2023","unstructured":"Lake, M. A., Adams, K. N., Nie, F., Fowler, E., Verma, A. K., Dei, S., Teodori, E., Sherman, D. R., Edelstein, P. H., Spring, D. R., & Troll, M. (2023). The human proton pump inhibitors inhibit Mycobacterium tuberculosis rifampicin efflux and macrophage-induced rifampicin tolerance. Proceedings of the National Academy of Sciences U S A., 120(7), e2215512120.","journal-title":"Proceedings of the National Academy of Sciences U S A."},{"issue":"117","key":"1299_CR48","first-page":"20051","volume":"21","author":"B St\u00e4llberg","year":"2020","unstructured":"St\u00e4llberg, B., Janson, C., Lind\u00e9n, A., Lisspers, K., & Larsson, K. (2020). The role of inhaled steroids in the treatment of COPD. L\u00e4kartidningen, 21(117), 20051.","journal-title":"L\u00e4kartidningen"},{"issue":"2","key":"1299_CR49","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1378\/chest.118.2.567","volume":"118","author":"WW Yew","year":"2000","unstructured":"Yew, W. W., Lee, J., & Chau, C. H. (2000). Role of inhaled budesonide in the treatment of tuberculous pyrexia. Chest, 118(2), 567.","journal-title":"Chest"},{"issue":"3","key":"1299_CR50","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1002\/ppul.20223","volume":"40","author":"A Auais","year":"2005","unstructured":"Auais, A., Wedde-Beer, K., & Piedimonte, G. (2005). Anti-inflammatory effect of albuterol enantiomers during respiratory syncytial virus infection in rats. Pediatric Pulmonology, 40(3), 228\u2013234.","journal-title":"Pediatric Pulmonology"}],"container-title":["Molecular Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12033-024-01299-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12033-024-01299-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12033-024-01299-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T19:02:28Z","timestamp":1759258948000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12033-024-01299-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,24]]},"references-count":50,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["1299"],"URL":"https:\/\/doi.org\/10.1007\/s12033-024-01299-z","relation":{},"ISSN":["1073-6085","1559-0305"],"issn-type":[{"value":"1073-6085","type":"print"},{"value":"1559-0305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,24]]},"assertion":[{"value":"26 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}